Lingying Wu , Ning Li , Jing Wang , Qingshui Li , Danbo Wang , Junying Tang , Cuiying Zhang , Guonan Zhang , Min Hao , Desheng Yao , Wei Duan , Qinglei Gao , Li Wang , Youzhong Zhang , Ruifang An , Rutie Yin , Qi Zhou , Hongying Yang , Jianqing Zhu , Kui Jiang , Bo Li
{"title":"Fuzuloparib 作为一线铂类化疗反应后晚期卵巢癌患者的维持疗法:一项随机、安慰剂对照III期试验的结果","authors":"Lingying Wu , Ning Li , Jing Wang , Qingshui Li , Danbo Wang , Junying Tang , Cuiying Zhang , Guonan Zhang , Min Hao , Desheng Yao , Wei Duan , Qinglei Gao , Li Wang , Youzhong Zhang , Ruifang An , Rutie Yin , Qi Zhou , Hongying Yang , Jianqing Zhu , Kui Jiang , Bo Li","doi":"10.1016/j.ygyno.2024.07.110","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":12853,"journal":{"name":"Gynecologic oncology","volume":null,"pages":null},"PeriodicalIF":4.5000,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Fuzuloparib as maintenance therapy among patients with advanced ovarian cancer after a response to first-line platinum-based chemotherapy: Results from a randomized, placebo-controlled, phase III trial\",\"authors\":\"Lingying Wu , Ning Li , Jing Wang , Qingshui Li , Danbo Wang , Junying Tang , Cuiying Zhang , Guonan Zhang , Min Hao , Desheng Yao , Wei Duan , Qinglei Gao , Li Wang , Youzhong Zhang , Ruifang An , Rutie Yin , Qi Zhou , Hongying Yang , Jianqing Zhu , Kui Jiang , Bo Li\",\"doi\":\"10.1016/j.ygyno.2024.07.110\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":12853,\"journal\":{\"name\":\"Gynecologic oncology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2024-10-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Gynecologic oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0090825824004657\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gynecologic oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0090825824004657","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
Fuzuloparib as maintenance therapy among patients with advanced ovarian cancer after a response to first-line platinum-based chemotherapy: Results from a randomized, placebo-controlled, phase III trial
期刊介绍:
Gynecologic Oncology, an international journal, is devoted to the publication of clinical and investigative articles that concern tumors of the female reproductive tract. Investigations relating to the etiology, diagnosis, and treatment of female cancers, as well as research from any of the disciplines related to this field of interest, are published.
Research Areas Include:
• Cell and molecular biology
• Chemotherapy
• Cytology
• Endocrinology
• Epidemiology
• Genetics
• Gynecologic surgery
• Immunology
• Pathology
• Radiotherapy